Literature DB >> 25234380

Epidemiology of Enterobacteriaceae producing CTX-M type extended spectrum β-lactamase (ESBL).

H Lahlaoui1, A Ben Haj Khalifa2, M Ben Moussa1.   

Abstract

Over the past 20 years, some Enterobacteriaceae mainly Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis have demonstrated acquisition of plasmids secreting ESBL. CTX-M type ESBL have been isolated worldwide and their incidence has increased dramatically and is still increasing leading to a major therapeutic issue. Currently more than 150 allelic variants of CTX-M have been identified. These enzymes are classified in five major phylogenetic groups based on their gene sequences: CTX-M -1, CTX-M-2, CTX-M-8, CTX-M-9, CTX-M-25; two additional groups have been reported recently: CTX-M-74 and CTX-M-75. The important dissemination of these enzymes has led to an increased use of carbapenems. Their global community and nosocomial dissemination is often associated with a virulent E. coli clone ST131 producing CTX-M-15.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CTX-M; Enterobacteriaceae; Entérobactéries; Extended-spectrum-β-lactamase; β-lactamase à spectre élargi

Mesh:

Substances:

Year:  2014        PMID: 25234380     DOI: 10.1016/j.medmal.2014.03.010

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  19 in total

Review 1.  Incompatibility Group I1 (IncI1) Plasmids: Their Genetics, Biology, and Public Health Relevance.

Authors:  Steven L Foley; Pravin R Kaldhone; Steven C Ricke; Jing Han
Journal:  Microbiol Mol Biol Rev       Date:  2021-04-28       Impact factor: 11.056

2.  Molecular characterization of extended-spectrum beta-lactamases (ESBLs) produced by clinical isolates of Acinetobacter baumannii in Saudi Arabia.

Authors:  Essam J Alyamani; Mohamed A Khiyami; Rayan Y Booq; Basel M Alnafjan; Musaad A Altammami; Fayez S Bahwerth
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-08-20       Impact factor: 3.944

3.  Antimicrobial susceptibility and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae from intensive care units at Hamad Medical Corporation, Qatar.

Authors:  Mazen A Sid Ahmed; Devendra Bansal; Anushree Acharya; Asha A Elmi; Jemal M Hamid; Abuelhassan M Sid Ahmed; Prem Chandra; Emad Ibrahim; Ali A Sultan; Sanjay Doiphode; Naser Eldin Bilal; Anand Deshmukh
Journal:  Antimicrob Resist Infect Control       Date:  2016-02-09       Impact factor: 4.887

4.  Characteristics and genetic diversity of multi-drug resistant extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from bovine mastitis.

Authors:  Tariq Ali; Sadeeq Ur Rahman; Limei Zhang; Muhammad Shahid; Dandan Han; Jian Gao; Shiyao Zhang; Pamela L Ruegg; Umer Saddique; Bo Han
Journal:  Oncotarget       Date:  2017-10-04

5.  High prevalence of blaCTX-M and blaSHV among ESBL producing E. coli isolates from beef cattle in China's Sichuan-Chongqing Circle.

Authors:  Yu-Long Zhang; Fang-Yuan Huang; Lin-Li Gan; Xin Yu; Dong-Jie Cai; Jing Fang; Zhi-Jun Zhong; Hong-Rui Guo; Yue Xie; Jun Yi; Zhi-Sheng Wang; Zhi-Cai Zuo
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

6.  Occurrence and characteristics of extended spectrum beta-lactamases-producing Enterobacteriaceae from foods of animal origin.

Authors:  İsmail Hakkı Tekiner; Haydar Özpınar
Journal:  Braz J Microbiol       Date:  2016-03-02       Impact factor: 2.476

7.  CTX-M extended-spectrum β-lactamase-producing Klebsiella spp, Salmonella spp, Shigella spp and Escherichia coli isolates in Iranian hospitals.

Authors:  Abed Zahedi Bialvaei; Hossein Samadi Kafil; Mohammad Asgharzadeh; Mohammad Aghazadeh; Mehdi Yousefi
Journal:  Braz J Microbiol       Date:  2016-04-22       Impact factor: 2.476

8.  Prevalence and characterization of extended-spectrum beta-lactamases producing Enterobacteriaceae in healthy children and associated risk factors.

Authors:  S M Hijazi; M A Fawzi; F M Ali; K H Abd El Galil
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-01-29       Impact factor: 3.944

9.  Virulence genes and subclone status as markers of experimental virulence in a murine sepsis model among Escherichia coli sequence type 131 clinical isolates from Spain.

Authors:  Irene Merino; Stephen B Porter; Brian D Johnston; Connie Clabots; Evelyn Shaw; Juan Pablo Horcajada; Rafael Cantón; Patricia Ruiz-Garbajosa; James R Johnson
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

10.  Prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan.

Authors:  Samyyia Abrar; Shahida Hussain; Rehan Ahmad Khan; Noor Ul Ain; Hayat Haider; Saba Riaz
Journal:  Antimicrob Resist Infect Control       Date:  2018-02-20       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.